357 0 Kommentare Global $25 Billion Biosensors Market, 2022 - Seite 3

2.1 Technological Advancements in Point-of-Care Testing Further Promotes Growth of Biosensors
2.2 Glucose Monitoring in Diabetes Worldwide Fueling the Growth of Biosensor Market
2.3 Growing Emergence of Biosensors in Environmental Application
2.4 Safety & Bio-Defense - The Emerging Field of Biosensors
2.5 Optical Biosensors Leads the Growth of Biosensors Industry Driven by Emergence of New Technologies

3. Biosensors Research & Developments Activities
3.1 Nano Tattoos as Biosensors for Medical Diagnostic Applications
3.2 New Novel Biosensors for Testing Water
3.3 Implantable Biosensors
3.4 Graphene Biosensors
3.5 Wearable Biosensors

4. Key Global Players

Abbott Laboratories, Inc. (United States)
Acon Laboratories, Inc. (United States)
Bayer AG (Germany)
Bio-Rad Laboratories, Inc. (United States)
Danaher Corporation (United States)
E. I. Du Pont De Nemours and Company (United States)
EMD Millipore Corporation (United States)
Ercon Inc. (United States)
GE Healthcare Ltd. (United Kingdom)
Integrated DNA Technologies, Inc. (United States)
Johnson & Johnson (United States)
Medtronic, Inc. (United States)
Nova Biomedical Corporation (United States)
Origene Technologies, Inc. (United States)
Pathsensors, Inc. (United States)
Perkinelmer, Inc. (United States)
Pharmaco-Kinesis Corporation (United States)
Qiagen N.V. (The Netherlands)
Roche Diagnostics Corporation (United States)
Siemens Healthineers (Germany)
Smiths Group Plc (United Kingdom)
Sysmex Corporation (Japan)
Thermo Fisher Scientific, Inc. (United States)
Universal Biosensors, Inc. (Australia)

5. Key Business & Product Trends

Abbott's FreeStyle Libre Glucose Monitoring System Reimbursement in Japan
Nanomedical Diagnostics' New NHS Agile Biosensor Chip for Use on Agile R100 Label-free Personal Assay System
Abbott and Bigfoot Enter into Collaboration to Develop Diabetes Technologies
New NTA Biosensor Chip Launched for use with Label-free Agile R100 Assay System
Abbott to Expand its FreeStyle Libre Flash Glucose Monitoring System Coverage in Canada
CE Mark for Abbott's TactiCath Contact Force Ablation Catheter
Release of Fully Automated Solution for Cell Culture Sampling and Complete Analysis for Bench-Scale Bioreactor Cultures
Nanomedical Diagnostics' AGILE R100 Graphene Biosensor Received Patent from USPTO
Aerialtronics Joined Forces with RAE Systems BeNeLux for Developing the Altura Zenith ATX8 UAS
BD's First Step in the Fight against Antimicrobial Resistance
CardioMEMS HF System from Abbott Aid in Heart Failure Hospitalizations
Nanomedical Diagnostics and Rogue Valley Microdevices Partnered to Deliver AGILE R100 Graphene Biosensor
FLEXcon and Polestar Join Forces
Finesse Solutions Acquired by Thermo Fisher Scientific
PathSensors and USDA's Agricultural Research Service team to Develop Bio Sensor Technology for Citrus Greening Disease
Cepheid Became an Indirect Wholly Owned Subsidiary of Danaher
PathSensors, Inc Develops Universal BioSensor Technology
PathSensors Introduces New High Speed Diagnostic Plant Pathogen Assays
Smith Detection Enhances IONSCAN 600 Detector Capabilities
MBiotech Acquired by Integrated DNA Technologies
Biosensors International Enters into Distribution Agreement with CORDIS
BioProfile FLEX2, the Next Addition to the BioProfile Line of Cell Culture Chemistry Analyzers
Affymetrix Acquired by Thermo Fisher Scientific
LifeScan Launches Onetouch Verio Flex Blood Glucose Monitoring System
Animas Vibe Insulation Pump and Continuous Glucose Monitoring System Received FDA Approval for Diabetes Management in Children Ages Two and Older
New Drger Tcore Sensor for Non-Invasive and Accurate Measurement of Body's Core Temperature
Nanomedical Diagnostics, Inc. Launched to Supply Monitoring and Diagnostic Platforms
QIAGEN, the First New Entrant in the US Market for STR Test Kits
New Exotic Gas Sensors are Now Available for Honeywell's QRAE 3 Gas Detector
LifeScan Launches the New OneTouch Verio Sync Meter